| Identification | More | [Name]
DL-2-AMINO-4-PENTENOIC ACID | [CAS]
7685-44-1 | [Synonyms]
2-AMINO-4-PENTENOIC ACID
DL-2-ALLYL GLYCINE
DL-2-AMINO-4-PENTENOIC ACID
DL-ALLYLGLYCINE
DL-C-ALLYLGLYCINE
H-ALLYL-DL-GLYCINE
H-DL-GLY(ALLYL)-OH
4-Pentenoic acid, 2-amino-, (.+/-.)-
dl-2-Amino-1-pentenoic acid
DL-2-aminopent-4-enoic acid
DL-Allylglycine 2-Amino-4-pentenoic acid
ALLYLGLYCINE[ALLYGLY]
(+/-)-2-AMINO-4-PENTENOIC ACID BIOCHEMIKA
2-Amino-4-pentanoic acid
2-Aminopent-4-enoic acid
C-allylglycine
(±)-2-Amino-4-pentenoic acid, DL-C-Allylglycine
rac-(2R*)-2-Amino-4-pentenoic acid
rac-(R*)-2-Allylglycine | [EINECS(EC#)]
231-689-8 | [Molecular Formula]
C5H9NO2 | [MDL Number]
MFCD00063103 | [Molecular Weight]
115.13 | [MOL File]
7685-44-1.mol |
| Chemical Properties | Back Directory | [Appearance]
white crystalline powder | [Melting point ]
258-260 °C(lit.) | [Boiling point ]
215.41°C (rough estimate) | [density ]
1.1808 (rough estimate) | [refractive index ]
1.4538 (estimate) | [storage temp. ]
2-8°C
| [Water Solubility ]
Soluble in water | [form ]
Crystalline Powder | [pka]
2.22±0.10(Predicted) | [color ]
White | [BRN ]
1748645 | [CAS DataBase Reference]
7685-44-1(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin .
R43:May cause sensitization by skin contact. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37:Wear suitable protective clothing and gloves .
S36:Wear suitable protective clothing . | [WGK Germany ]
3
| [HS Code ]
29224999 |
| Hazard Information | Back Directory | [Chemical Properties]
white crystalline powder | [Biochem/physiol Actions]
DL-2-Allylglycine is a racemic mixture of L- and D-allylglycine. D-allylglycine is the enantiomer of L-allylglycine, a glutamate decarboxylase (GAD) inhibitor used in GABA research. D-allylglycine may be used as a control supplement versus L-allylglycine in GABA research. D-allylglycine is used in the organic synthesis of cyclic opioid peptide agonists and antagonists. | [Purification Methods]
Dissolve it in absolute EtOH and precipitate it with pyridine, then recrystallise it from aqueous EtOH [RF on paper in BuOH/EtOH/NH3/H2O (4:4:1:1:) is 0.37]. The hydrobromide has m 136-140o (from EtOAc) and the phenylureido derivative has m 159-161o. [Schgl Monatsh Chem 89 377 1958, Beilstein 4 IV 2852.] |
|
|